Dario Braga

USPTO Granted Patents = 22 (Patent Applications = 27)

CIPO Patents = 5

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 6.7

ph-index = 13

Forward Citations = 375(Granted Patents)

Location History:

Casalecchio di Reno, IT (2015 - 2017)
Bologna, IT (2006 - 2020)

Company Filing History:

17 out of 88

Alfa Wassermann, Inc.

Years Active: 2006-2020

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10703763 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations (2020-07-07),

2. 9624192 - Carbamate/urea derivatives (2017-04-18),

3. 9498442 - Rifaximin powder, process for preparing the same an controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect (2016-11-22),

4. 9452157 - Pharmaceutical compositions comprising rifaximin and amino acids, preparation methods and use thereof (2016-09-27),

5. 9273026 - Carbamate/urea derivatives (2016-03-01),

6. 9271968 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations (2016-03-01),

7. 9034874 - Carbamate/urea derivatives (2015-05-19),

8. 8853231 - Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin (2014-10-07),

9. 8835452 - Polymorphic forms α, β and γ of rifaximin (2014-09-16),

10. 8748447 - Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect (2014-06-10),

11. 8741904 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations (2014-06-03),

12. 8518949 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations (2013-08-27),

13. 8193196 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations (2012-06-05),

14. 8173801 - Processes for the production of polymorphic forms of rifaximin (2012-05-08),

15. 8158781 - Polymorphic forms α, β and γ of rifaximin (2012-04-17),

Title: Dario Braga: Innovator in Medicinal Chemistry

Introduction

Dario Braga is a prominent inventor based in Bologna, Italy, known for his significant contributions to medicinal chemistry. With a remarkable portfolio of 19 patents, he has focused on advancements in pharmaceutical formulations, particularly related to the antibiotic rifaximin.

Latest Patents

Among Dario Braga's latest inventions are two notable patents that enhance the therapeutic application of rifaximin. The first patent titled "Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations" details crystalline forms of rifaximin, specifically rifaximin δ and rifaximin ε. This invention outlines a crystallization process that involves dissolving rifaximin in ethyl alcohol and inducing crystallization through a controlled addition of water at set temperatures. This method results in medicinal preparations that are effective for both oral and topical applications.

The second patent, "Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect," elucidates a novel process for creating rifaximin powder. This invention also includes a pharmaceutical composition that allows for the controlled release of rifaximin, ensuring a prolonged effect for patients when administered orally.

Career Highlights

Dario has established himself in the pharmaceutical industry through his instrumental roles at companies such as Alfa Wassermann S.p.A. and Alfasigma S.p.A. His work in these organizations has been pivotal in advancing drug formulation techniques and optimizing medicinal products for better patient outcomes.

Collaborations

Throughout his career, Dario Braga has collaborated with notable professionals including Giuseppe Claudio Viscomi and Donatella Confortini. These collaborations have enriched his research and development efforts, leading to innovative solutions in drug delivery systems.

Conclusion

In conclusion, Dario Braga's contributions to medicinal chemistry, particularly through his patents on rifaximin formulations, underscore his role as an influential inventor in the field. His innovative approaches not only advance pharmaceutical science but also promise improved therapeutic outcomes for patients.

This text is generated by artificial intelligence and may not be accurate.